Clin2
NCT06707389Possibly a fitNot yet recruiting

Blood cell therapy for sudden hearing loss

Sudden DeafnessSensorineural Hearing Loss

Treatments studied

Part of Brain & nervous system, Ear, nose & throat clinical trials.

This study tests an experimental treatment made from your own blood cells to help restore hearing after sudden deafness. It is for people who have had severe hearing loss in one ear for less than three weeks and have not had ear injections yet.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
30 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have sudden, severe hearing loss in one ear that started within the last 3 weeks.
  • You have not had ear injections (intratympanic) for this hearing loss.
  • You do not have other ear problems or serious health conditions that might interfere.
  • You are not pregnant or breastfeeding, and agree to use effective birth control if needed.
  • You are willing to participate, sign a consent form, and follow the study plan.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07472023Enrolling by invitation· Early Phase 1
Stem cell therapy for hearing loss and tinnitus

This trial tests a regenerative stem cell treatment for people with hearing loss, tinnitus, or inner ear injury. It aims to see if the therapy can improve hearing or reduce symptoms.

New York, New York
NCT07860580Recruiting
Blood markers in children with congenital hearing loss

This study looks at certain substances in the blood of children with congenital hearing loss (hearing loss present from birth) to see if they are different from children with normal hearing. It may help doctors understand why hearing loss happens and could lead to better treatments.

Sanliurfa
NCT07404709Not yet recruiting· Phase 1/Phase 2
Stem cell injection for sudden severe hearing loss

This trial tests a new treatment for severe sudden hearing loss. A solution containing tiny particles from stem cells is injected into the ear to see if it can improve hearing and is safe.

Guangzhou, Guangdong
NCT07568184Recruiting
New Exosome Treatment for Sudden Hearing Loss

This trial tests a new way to deliver anti-inflammatory medicine directly into the ear using tiny particle carriers called exosomes. It's designed for people who lost hearing suddenly without a clear cause and didn't improve with standard steroid pills.

Kafr ash Shaykh, Egypt
NCT07540728Not yet recruiting· Phase 2
Steroid treatment through the inner ear for sudden hearing loss

This trial tests whether giving steroids directly into the inner ear can improve hearing in people with profound sudden hearing loss that didn't improve with standard treatment. It aims to see if this treatment can help recover more hearing.

Shanghai, Shanghai Municipality
NCT06819202Not yet recruiting
Oxygen therapy for sudden hearing loss

This trial tests if breathing extra oxygen in a special chamber (hyperbaric oxygen therapy) can improve sudden hearing loss and blood clotting. It may help if you have had hearing loss for less than two weeks.

Shanghai, Putuo

Hear when a new Sudden Deafness trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.